0000000000749610

AUTHOR

Mercedes Ramón Capilla

showing 2 related works from this author

Neumonía neumocócica en pacientes hospitalizados. Implicaciones terapéuticas de las resistencias a la penicilina y la eritromicina

2003

Fundamento Y Objetivo Streptococcus pneumoniaees el principal causante de la neumonia comunitaria.El objetivo del estudio fue analizar lasresistencias del neumococo a la penicilina y eritromicina,asi como su influencia en la evolucionde la enfermedad. Pacientes Y Metodo Se realizo un analisis retrospectivode 75 pacientes con neumonia neumococicahospitalizada valorando factores de comorbilidady sensibilidad a betalactamicos yeritromicina. Resultados Sesenta y siete pacientes (89,3%)presentaban factores de comorbilidad. El49,3% de las cepas presentaba algun tipo deresistencia: el 38,6% a la penicilina, el 36% ala eritromicina y el 13,3% a la cefotaxima. Nose observo relacion entre la gravedad…

business.industryMedicineGeneral MedicinebusinessHumanitiesMedicina Clínica
researchProduct

Antisynthetase syndrome (AS) in patients with diffuse interstitial lung disease (ILD)

2015

Objectives: To determine the prevalence of SAS in patients with ILD and its clinical characteristics, evolution and specific manifestations linked to each antisynthetase antibodies and highlight the need for its screening in ILD. Methods: Retrospective analysis of patients registered in the last two years in our ILD unit, determining antisynthetase antibodies and analyzing clinical, radiological, functional data and illness evolution. Results: 119 ILD patients were included, 10.9% had antisynthetase antibodies, the most prevalent were Jo-1 (46.1%) and PL-12 (38.5%). In PL-12 patients inicial and respiratory syntoms were predominant, whereas in the Jo-1 patients were more frequent extrapulmo…

medicine.medical_specialtyPathologybusiness.industryInterstitial lung diseaseAntisynthetase syndromerespiratory systemmedicine.diseasebehavioral disciplines and activitiesResponse to treatmentrespiratory tract diseasesbody regionsFEV1/FVC ratioInternal medicinemedicineRetrospective analysisIn patientRespiratory systembusinessInterstitial Disease1.5 Diffuse Parenchymal Lung Disease
researchProduct